Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

10x Genomics (TXG) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to -$0.13.

  • 10x Genomics' EPS (Basic) rose 6829.27% to -$0.13 in Q4 2025 from the same period last year, while for Dec 2025 it was -$0.35, marking a year-over-year increase of 7712.42%. This contributed to the annual value of -$0.35 for FY2025, which is 7697.37% up from last year.
  • 10x Genomics' EPS (Basic) amounted to -$0.13 in Q4 2025, which was up 6829.27% from -$0.22 recorded in Q3 2025.
  • 10x Genomics' EPS (Basic)'s 5-year high stood at $0.28 during Q2 2025, with a 5-year trough of -$0.79 in Q3 2023.
  • In the last 5 years, 10x Genomics' EPS (Basic) had a median value of -$0.31 in 2024 and averaged -$0.3.
  • Per our database at Business Quant, 10x Genomics' EPS (Basic) crashed by 47000.0% in 2022 and then skyrocketed by 18750.0% in 2025.
  • Quarter analysis of 5 years shows 10x Genomics' EPS (Basic) stood at -$0.17 in 2021, then rose by 11.76% to -$0.15 in 2022, then crashed by 173.33% to -$0.41 in 2023, then grew by 0.0% to -$0.41 in 2024, then soared by 68.29% to -$0.13 in 2025.
  • Its EPS (Basic) was -$0.13 in Q4 2025, compared to -$0.22 in Q3 2025 and $0.28 in Q2 2025.